Index to Diseases (FY04)

Celiac Disease Biomarker development Project. $ 23,076.50. $ 143,160.00. Amaranth Medical Inc. Coronary Artery Vascular Restoration Therapy Drug Eluting Bioresorbable Stent. $ 244,479.24 Amaranth Medical, Inc. Drug Eluting Bioresorable Stent for PVD Vascular Restoration Therapy. $ 244,479.24 Ambit Biosciences Inc. AC220 (FLT3) Program. $ 244,479.24 ................
................

In order to avoid copyright disputes, this page is only a partial summary.